--- title: "Drug Depot, Inc., dba APS Pharmacy Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Drug Depot, Inc., dba APS Pharmacy recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/drug-depot-inc-dba-aps-pharmacy/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Drug Depot, Inc., dba APS Pharmacy recall records **0** reported ongoing 8 records in this archive. Latest source date Mar 23, 2022. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Mar 23, 2022 FDA drug enforcement ### [GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0728-2022-gonadorelin-5ml-0-2-mg-ml-injectable-packaged-in-a-multi-dose-10ml-vial-formula-id132227-aps-pharmac/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for GONADORELIN (5ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID132227, APS...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0728-2022%22) Mar 23, 2022 FDA drug enforcement ### [(CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID136345, APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0729-2022-ca-gonadorelin-4ml-0-2-mg-ml-injectable-packaged-in-a-multi-dose-10ml-vial-formula-id136345-aps-pha/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for (CA) GONADORELIN (4ML) 0.2 MG/ML INJECTABLE, Packaged in a multi dose 10ML vial, Formula ID136345...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0729-2022%22) Mar 23, 2022 FDA drug enforcement ### [TESTOSTERONE CYPIONATE/ANASTROZOLE \*GS\* OIL 200MG/1MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 4 ML Formula ID 115387; b) (RM) 10 ML Formula ID 115125; APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0730-2022-testosterone-cypionate-anastrozole-gs-oil-200mg-1mg-ml-injectable-packaged-in-a-multi-dose-10ml-vial/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for TESTOSTERONE CYPIONATE/ANASTROZOLE \*GS\* OIL 200MG/1MG/ML Injectable, Packaged in a multi dose 10M...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0730-2022%22) Mar 23, 2022 FDA drug enforcement ### [TESTOSTERONE CYPIONATE/ ANASTROZOLE \*GS\* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar](https://isitonrecall.com/recall/fda-drug-d-0731-2022-testosterone-cypionate-anastrozole-gs-oil-10ml-200mg-0-5mg-ml-packaged-in-a-multi-dose-10ml-vial-as/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for TESTOSTERONE CYPIONATE/ ANASTROZOLE \*GS\* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0731-2022%22) Mar 23, 2022 FDA drug enforcement ### [TESTOSTERONE CYPIONATE/ DHEA \*GS\* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as a) 5 ML Formula ID 115678; b) 10 ML Formula ID 115498, APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0732-2022-testosterone-cypionate-dhea-gs-200-10mg-ml-injectable-packaged-in-a-multi-dose-10ml-vial-as-a-5-ml-f/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for TESTOSTERONE CYPIONATE/ DHEA \*GS\* 200/10MG/ML Injectable, Packaged in a multi dose 10ML vial, as ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0732-2022%22) Mar 23, 2022 FDA drug enforcement ### [TESTOSTERONE CYPIONATE/PROPIONATE \*SES\* Oil (10 ML) 160MG/20MG/ML Injectable, Packaged in a multi dose 10ml vial, Formula ID 115498, APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0733-2022-testosterone-cypionate-propionate-ses-oil-10-ml-160mg-20mg-ml-injectable-packaged-in-a-multi-dose-10/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for TESTOSTERONE CYPIONATE/PROPIONATE \*SES\* Oil (10 ML) 160MG/20MG/ML Injectable, Packaged in a multi...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0733-2022%22) Mar 23, 2022 FDA drug enforcement ### [TESTOSTERONE CYPIONATE \*GS\* Oil 200 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 76681, APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0734-2022-testosterone-cypionate-gs-oil-200-mg-ml-injectable-packaged-in-a-multi-dose-10ml-vial-formula-id-766/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for TESTOSTERONE CYPIONATE \*GS\* Oil 200 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0734-2022%22) Mar 23, 2022 FDA drug enforcement ### [TESTOSTERONE CYPIONATE \*GS\* (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formula ID 127492, APS Pharmacy](https://isitonrecall.com/recall/fda-drug-d-0735-2022-testosterone-cypionate-gs-2-ml-80-mg-ml-injectable-packaged-in-a-multi-dose-10ml-vial-formula-id-127/) Lack of sterility assurance. Class II Reported terminated Distribution: Nationwide in the USA including Puerto Rico. [Official source for TESTOSTERONE CYPIONATE \*GS\* (2 mL) 80 MG/ML Injectable, Packaged in a multi dose 10ML vial, Formu...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0735-2022%22) ## Reasons in these listed records - Lack of sterility assurance. These examples come from this result page and are not a ranking of every recall reason. ## Checking Drug Depot, Inc., dba APS Pharmacy ### Is there a recall on drug depot, inc., dba aps pharmacy right now? This archive contains 8 records, including 0 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Drug Depot, Inc., dba APS Pharmacy](https://isitonrecall.com/check/?q=Drug%20Depot%2C%20Inc.%2C%20dba%20APS%20Pharmacy) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)